Manhattan Bridge (LOAN) 4.56 $LOAN Manhattan Bridge

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Manhattan Bridge (LOAN) 4.56 $LOAN

Manhattan Bridge Capital, Inc. Declares Quarterly Dividend
GlobeNewswire - Mon May 02, 3:09PM CDT
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced today that its board of directors had approved a $0.09 per share quarterly dividend to be paid to all shareholders of record on July 8, 2016 with pay date on July 15, 2016.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital Reports 46.0% Increase in Net Income
GlobeNewswire - Mon May 02, 6:34AM CDT
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced today that net income for the three month period ended March 31, 2016 was approximately $695,000 or $0.10 per share, versus approximately $476,000 or $0.08 per share for the three month period ended March 31, 2015, an increase in net income of 46.0% or in earnings per share of 25%. This increase is primarily attributable to the increase in revenue and the decrease in operating expenses.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital, Inc. Announces Closing of Public Offering of Senior Secured Notes by its Wholly Owned Subsidiary MBC Funding II Corp.
GlobeNewswire - Mon Apr 25, 4:40PM CDT
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN), a "hard money" lender specializing in short-term loans secured by real estate, today announced the closing of its previously announced public offering of $6,000,000 aggregate principal amount of 6% senior secured notes due April 22, 2016 by its wholly-owned subsidiary, MBC Funding II Corp (NYSE MKT:LOAN/26). Manhattan Bridge Capital is guaranteeing MBC Funding's obligations under the Notes and pledged 100% of Funding's equity to secure its obligations under the guarantee. The gross proceeds to Funding from this offering are $6,000,000, before deducting underwriting discounts and commissions and other estimated offering expenses.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital, Inc. Prices $6,000,000 Offering of Senior Secured Notes Issued by Its Wholly-Owned Subsidiary, MBC Funding II Corp
GlobeNewswire - Fri Apr 15, 4:30PM CDT
Manhattan Bridge Capital Inc. (NASDAQ:LOAN) ("LOAN" or "the Company", MBC Funding II Corp (NYSE:LOAN/26) ("Funding", a real estate lender specializing in short-term, "hard money" real estate loans, today announced the pricing of an underwritten public offering by its wholly owned subsidiary, MBC Funding II Corp ("Funding" of $6,000,000 aggregate principal amount of Funding's 6% senior notes due April 30, 2026. MBC is guaranteeing Funding's obligations under the Notes and pledged 100% of Funding's equity to secure its obligations under the guarantee. The gross proceeds to Funding from this offering are expected to be approximately $6,000,000, before deducting underwriting discounts and commissions and other estimated offering expenses. The offering is expected to close on April 22, 2016, subject to customary closing conditions.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital, Inc. Announces Payment of Quarterly $0.085 per Share Dividend
GlobeNewswire - Fri Apr 01, 6:00AM CDT
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced today that, in accordance with the board approved dividend declared on February 11, 2016, a cash dividend of $0.085 per share will be paid to all shareholders of record on April 8, 2016 with pay date on April 15, 2016.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital, Inc. Declares Increased Quarterly Dividend of $0.085 Per Share
GlobeNewswire - Mon Nov 02, 6:00AM CST
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced today that its board of directors had approved an increased $0.085 per share quarterly dividend to be paid to all shareholders of record on December 31, 2015 with pay date on January 15, 2016.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital, Inc. Announces Closing of Over-Allotment Option Shares
GlobeNewswire - Wed Jun 24, 10:54AM CDT
Manhattan Bridge Capital, Inc. (Nasdaq:LOAN), a "hard money" lender specializing in short-term loans secured by real estate, today announced that, on June 19, 2015, Aegis Capital Corp., the sole underwriter of its previously announced public offering of 1,015,000 common shares at a price to the public of $4.39 per share, has elected to partially exercise the over-allotment option for an additional 105,000 common shares. The closing with respect to these over-allotment option shares was consummated on June 24, 2015. Gross proceeds to Manhattan Bridge Capital from the sale of the over-allotment option shares will be $460,950 resulting in total gross proceeds from the offering of approximately $4,920,000, before deducting underwriting discounts and commissions and other estimated offering expenses. The over-allotment option covers a total of 152,250 common shares, of which 47,250 remain, and expires July 6, 2015.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital, Inc. Announces Closing of Public Offering
GlobeNewswire - Fri May 29, 11:06AM CDT
Manhattan Bridge Capital, Inc. (Nasdaq:LOAN), a "hard money" lender specializing in short-term loans secured by real estate, today announced the closing of its previously announced public offering of 1,015,000 common shares at a price to the public of $4.39 per share. Gross proceeds to Manhattan Bridge Capital from the offering were approximately $4,460,000, before deducting underwriting discounts and commissions and other estimated offering expenses. Manhattan Bridge Capital has granted the underwriters a 45-day option to purchase up to 152,250 additional common shares to cover over-allotments, if any.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital Announces Pricing of Public Offering of Common Shares
GlobeNewswire - Fri May 22, 4:09PM CDT
Manhattan Bridge Capital Inc. (Nasdaq:LOAN) ("the Company", a real estate lender specializing in short-term, "hard money" real estate loans, today announced the pricing of an underwritten public offering of 1,015,000 common shares, par value $0.001 per share, at a price to the public of $4.39 per share. The gross proceeds to Manhattan Bridge Capital from the public offering are expected to be approximately $4,450,000 before underwriting discounts and commissions and other estimated offering expenses. Manhattan Bridge Capital has granted the underwriter a 45-day option to purchase up to an additional 152,250 common shares from the Company to cover over-allotments, if any. The offering is expected to close on May 29, 2015, subject to customary closing conditions.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital Reports 49.8% Increase in First Quarter Revenues; 128% Increase in Net Income and 60% Increase in Earnings Per Share
GlobeNewswire - Mon May 04, 6:17AM CDT
Manhattan Bridge Capital, Inc. (Nasdaq:LOAN) announced today that total revenues for the three month period ended March 31, 2015 were approximately $912,000 compared to approximately $609,000 for the three month period ended March 31, 2014, an increase of $303,000 or 49.8%. The increase in revenue represents an increase in lending operations. In 2015, approximately $757,000 of our revenue represents interest income on secured, commercial loans that we offer to small businesses compared to approximately $507,000 for the same period in 2014, and approximately $155,000 represents origination fees on such loans compared to approximately $102,000 for the same period in 2014. The loans are principally secured by collateral consisting of real estate and, generally, accompanied by personal guarantees from the principals of the businesses.
LOAN: 4.56 (-0.04)

Manhattan Bridge Capital, Inc. Reports Results for 2014
GlobeNewswire - Mon Mar 23, 6:15AM CDT
Revenue Increases by 28.5% to Approximately $2.9 Million
LOAN: 4.56 (-0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ortho Molecular and HANS: Streamlining Functional Medicine

Updated Category News Views 130

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

Continue Reading
CURE Intl and Thoughtworks Step Into Digital Era

Updated Category News Views 117

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Continue Reading
Jinko Solar Joins B20 Summit: Energy Forefront Focus

Updated Category News Views 105

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Continue Reading
Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Updated Category News Views 47

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Continue Reading
Agilyx's Q3 Update: GreenDot Shines Amid Mixed Results

Updated Category News Views 130

Peeking into Agilyx's Financial Odyssey Just as I sip my morning coffee pondering the highs and lows of the market, here comes Agilyx ASA splashing some liquidity on the scene. The Q3 report paints the company in various shades—from solid greens to hesitant reds. Nothing like the thrill of untangling mixed results over a quiet day, huh? GreenDot's Climb to Profitability...

Continue Reading
Inflatable Wonders Turn Christmas into a Hoot at Lowe's

Updated Category News Views 27

Inflatables Bringing the Cheer (and Laughs) Well, it's that season again—where decorations either have us grumbling at the electric bill or chuckling at the lawn art. Lowe's has teamed up with Gemmy to serve a heaping platter of holiday giggles this year. They've rolled out a quirky lineup of inflatables that go from shivering Highland cows to dinosaurs and elves....

Continue Reading
LG Innotek Scores Hat Trick with CES Innovation Wins

Updated Category News Views 86

LG Innotek's Lighting Triumph Here we go again, LG Innotek just snagged their third CES Innovation Award in a row, this time for their cutting-edge vehicle lighting module, Nexlide C+. It's one for the books—breaking into the 2027 CES spotlight with innovative tech that not only grabs the eyes but could also steal the hearts of investors willing to bet on the future of...

Continue Reading
RF MEDICAL Expands into Europe with New CE Certification

Updated Category News Views 62

RF MEDICAL Secures CE Marking for Mi-BLATOR™ Just when you think the European medical device market's hit its saturation point, RF MEDICAL decides to kick the door open with their Mi-BLATOR™ microwave ablation system. This ain't just another plastic gadget, folks; it's got that shiny new CE marking under the European Union's Medical Device Regulation (MDR). Now, what...

Continue Reading
BD Sets Stage for Investor Day in December 2026

Updated Category News Views 9

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Continue Reading
Centrus Energy Welcomes Nuclear Veteran to Leadership

Updated Category News Views 14

Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...

Continue Reading

Top 5 Most Recently Viewed Articles

Oracle's Stellar Growth: A Deep Dive into Recent Surge

Updated Category News Views 389

Oracle Shares Experience Remarkable Growth in Trading In exciting news, Oracle Corp. (NYSE: ORCL) is making waves in the stock market, as its shares surge in value. This Texas-based enterprise software giant saw a significant increase, recording a 35.95% rise during the regular trading session. Following this impressive performance, a further increase of 1.42% in...

Continue Reading
Creative Global Technology Holdings Limited Reports 2024 Success

Updated Category News Views 329

Financial Overview of Creative Global Technology Holdings Limited Creative Global Technology Holdings Limited (NASDAQ: CGTL), renowned for sourcing and reselling recycled consumer electronics, has shared its impressive financial results for the fiscal year ending 2024. Despite a decrease in overall revenue, the company has achieved significant growth in gross profit and...

Continue Reading
Exciting Financial Insights Ahead for Gilat Satellite Networks

Updated Category News Views 173

Gilat Satellite Networks Set to Announce Financial Results Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), recognized globally as a frontrunner in satellite networking technology, is gearing up to announce its fourth quarter and full year 2024 financial results. The announcement is set for an engaging conference call on an upcoming Wednesday. Details of the...

Continue Reading
PKGD Group's Agave Spirits Surge 56% in 2026 Growth'

Updated Category News Views 84

PKGD Group's Impressive Growth Story Sometimes you read a report and it genuinely knocks the wind out of you—not because it’s unusual, but because it’s rare to see such robust numbers in a market that ain't exactly all sunshine and rainbows. PKGD Group, the brain behind some damn fine agave spirits, decided to take no prisoners this year, reporting a jaw-dropping...

Continue Reading
Analysts Raise Expectations for Booking Holdings After Earnings

Updated Category News Views 204

Booking Holdings Surprises Analysts with Earnings Report Booking Holdings (NASDAQ: BKNG) recently released its quarterly earnings, exceeding expectations and impressing industry analysts. With a strong report showcasing earnings of $99.50 per share, the company surpassed analysts' forecast of $95.25 per share significantly. Sales figures also bolstered investor...

Continue Reading